Developing a New Sprinkle Valbenazine Formulation to Advance the Treatment of Tardive Dyskinesia.

Published Date: 05 May 2024

Leslie Citrome, M.D., MPH, clinical professor of psychiatry and behavioral sciences at New York Medical College, discussed his thoughts on the newly authorized valbenazine sprinkle formulation for tardive dyskinesia patients.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The Boom in ADHD Coaching Has Few Rules

2.

Cancer patients with HIV have demonstrated safety with immune checkpoint inhibitors.

3.

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

4.

Medicaid expansion tied to smaller declines in early-stage cancer detection

5.

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot